In addition, genes targeting ADAM17 (Adam17ex/ex mice) and treatments (ADAM17 predomain inhibitors [A17pro]) improved experimental pancreatitis, which was associated with a reduction in the IL-6 transsignaling/STAT3 axis. This evidence concerns the gene ADAM17 and pancreatitis.